Internal Medicine, Gastroenterology · Los Angeles, CA
NPI
1376703280
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 UCLA Medical Plaza Suite 205
Los Angeles, CA, 90095
Phone (855) 423-8252
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
325 services
Medicare patients, 2024
123
Average age 69
Drug cost, 2024
$4.7M
844 prescriptions
Company payments, 2025
$45K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jenny Sauk was code 99214 (office e&m - established), 172 times for 96 patients. In total Jenny Sauk billed 325 services in 21 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 172 | 96 | $103.67 | $18K |
| 45380 Lower GI Endoscopy - Other | Facility | 42 | 42 | $95.40 | $4,007 |
| 45385 Colonoscopy - Lesion Removal | Facility | 18 | 18 | $205.79 | $3,704 |
| 99215 Office E&M - Established | Office | 18 | 13 | $150.96 | $2,717 |
| 99205 Office E&M - New | Office | 17 | 17 | $175.33 | $2,981 |
| 43239 Upper GI Endoscopy | Facility | 12 | 12 | $66.88 | $803 |
By year: 2022 $36K for 326 services; 2023 $32K for 277 services; 2024 $35K for 325 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jenny Sauk prescribed most often to Medicare patients was Mesalamine, with 120 prescriptions and refills. In total Jenny Sauk wrote 844 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mesalamine Generic | 120 | 270 | 27 | $89K |
| Stelara Ustekinumab | 90 | 121 | 14 | $2.4M |
| Humira(Cf) Pen Adalimumab | 73 | 84 | Under 11 | $716K |
| Methotrexate Methotrexate Sodium | 53 | 82 | Under 11 | $1,209 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 41 | 41 | 37 | $2,520 |
| Skyrizi On-Body Risankizumab-Rzaa | 36 | 67 | Under 11 | $764K |
| Rinvoq Upadacitinib | 29 | 29 | Under 11 | $180K |
| Dicyclomine Hcl Generic | 28 | 41 | Under 11 | $1,073 |
| Famotidine Generic | 25 | 49 | Under 11 | $305 |
| Mesalamine Er Mesalamine | 25 | 46 | Under 11 | $8,963 |
| Omeprazole Generic | 23 | 68 | Under 11 | $262 |
| Mercaptopurine Generic | 20 | 60 | Under 11 | $4,204 |
| Loperamide Loperamide Hcl | 17 | 22 | Under 11 | $1,016 |
| Colestipol Hcl Generic | 16 | 44 | Under 11 | $1,952 |
| Cholestyramine Cholestyramine (With Sugar) | 14 | 31 | Under 11 | $2,070 |
Brand drugs: 332 claims; generic drugs: 512 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jenny Sauk $45K ($45K in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $21K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.